Filing Details

Accession Number:
0000899243-19-024825
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-10-02 21:36:48
Reporting Period:
2019-09-30
Accepted Time:
2019-10-02 21:36:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1415684 Musclepharm Corp MSLP () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1008190 Mark Blundell C/o White Winston Select Asset Funds Llc
265 Franklin St., Suite 1702
Boston MA 02110
No No Yes No
1559652 P Robert Mahoney C/o White Winston Select Asset Funds Llc
265 Franklin St., Suite 1702
Boston MA 02110
No No Yes No
1647702 M. Todd Enright C/o White Winston Select Asset Funds Llc
265 Franklin St., Suite 1702
Boston MA 02110
No No Yes No
1647837 Donald Feagan C/o White Winston Select Asset Funds Llc
265 Franklin St., Suite 1702
Boston MA 02110
No No Yes No
1647840 White Winston Select Asset Funds, Llc 265 Franklin St., Suite 1702
Boston MA 02110
No No Yes No
1738154 White Winston Select Asset Fund Series Fund Mp-18, Llc 265 Franklin St., Suite 1702
Boston MA 02110
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-09-30 626,826 $0.00 3,658,180 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. On September 30, 2019, the Reporting Person purchased 626,826 shares of Common Stock, par value $0.001 per share, of the issuer ("Common Stock") in an off-market transaction.
  2. For purposes of the transaction, the value of the Common Stock was deemed to be $0.45 per share, the last reported sale price of the Common Stock on the Transaction Date.